Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Idera Pharmaceuticals (IDRA)

Idera Pharmaceuticals (IDRA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 53,817
  • Shares Outstanding, K 52,762
  • Annual Sales, $ 0 K
  • Annual Income, $ -112,660 K
  • 60-Month Beta 1.82
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.41
Trade IDRA with:

Options Overview Details

View History
  • Implied Volatility 99.88%
  • Historical Volatility 30.44%
  • IV Percentile 12%
  • IV Rank 10.77%
  • IV High 507.21% on 02/12/21
  • IV Low 50.69% on 09/07/21
  • Put/Call Vol Ratio 0.17
  • Today's Volume 74
  • Volume Avg (30-Day) 211
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 6,093
  • Open Int (30-Day) 6,419

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.23
  • Number of Estimates 1
  • High Estimate -0.23
  • Low Estimate -0.23
  • Prior Year -0.22
  • Growth Rate Est. (year over year) -4.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0000 +5.00%
on 09/21/21
1.1300 -7.08%
on 08/31/21
+0.0300 (+2.94%)
since 08/20/21
3-Month
0.9801 +7.13%
on 07/27/21
1.7100 -38.60%
on 06/23/21
-0.5300 (-33.54%)
since 06/22/21
52-Week
0.9710 +8.14%
on 05/13/21
6.1400 -82.90%
on 01/21/21
-1.4300 (-57.66%)
since 09/22/20

Most Recent Stories

More News
Idera Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Idera Pharmaceuticals, Inc. ("Idera" or the "Company") (Nasdaq: IDRA) today reported its financial and operational results for the second quarter ended June 30, 2021.

IDRA : 1.0500 (+2.94%)
Idera: Q2 Earnings Snapshot

EXTON, Pa. (AP) _ Idera Pharmaceuticals Inc. (IDRA) on Monday reported a loss of $7.6 million in its second quarter.

IDRA : 1.0500 (+2.94%)
BioCryst Appoints Vincent Milano to Board of Directors

BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has appointed hereditary angioedema (HAE) and rare disease industry leader, Vincent Milano, to its board of directors.

IDRA : 1.0500 (+2.94%)
BCRX : 15.39 (+0.46%)
Thinking about buying stock in Entera Bio, Torchlight Energy, Idera Pharmaceuticals, Nikola Corp, or Orphazyme?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ENTX, TRCH, IDRA, NKLA, and ORPH.

ENTX : 4.83 (+2.99%)
NKLA : 11.06 (+3.27%)
ORPH : 4.57 (+1.56%)
IDRA : 1.0500 (+2.94%)
TRCH : 4.95 (+4.21%)
Thinking about buying stock in Biocept, Histogen, Idera Pharmaceuticals, Satsuma Pharmaceuticals, or Clover Health Investments?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BIOC, HSTO, IDRA, STSA, and CLOV.

CLOV : 7.88 (+1.42%)
HSTO : 0.8108 (+2.52%)
STSA : 4.78 (+5.29%)
BIOC : 4.07 (+0.74%)
IDRA : 1.0500 (+2.94%)
Idera Pharmaceuticals Announces Corporate Updates

Idera Pharmaceuticals, Inc. ("Idera" or the "Company") (Nasdaq: IDRA) today announced that it will not continue ILLUMINATE-301, the Company's trial of tilsotolimod in combination with ipilimumab versus...

IDRA : 1.0500 (+2.94%)
Idera Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update

Idera Pharmaceuticals, Inc. ("Idera" or the "Company") (Nasdaq: IDRA) today reported its financial and operational results for the first quarter ended March 31, 2021.

IDRA : 1.0500 (+2.94%)
Idera: Q1 Earnings Snapshot

EXTON, Pa. (AP) _ Idera Pharmaceuticals Inc. (IDRA) on Thursday reported first-quarter profit of $115.7 million.

IDRA : 1.0500 (+2.94%)
Vyant Bio Announces Newly Appointed Board of Directors

Vyant Bio, Inc. (the "Company") (Nasdaq: VYNT), is a new force in drug discovery, focused on integrating human-powered scientific and technology-based systems to de-risk and accelerate the discovery of...

VYNT : 2.34 (+2.63%)
KYMR : 62.35 (+4.65%)
NANO : 35.33 (-0.81%)
LQDA : 2.79 (+7.31%)
IDRA : 1.0500 (+2.94%)
SNDX : 18.82 (+1.35%)
Thinking about buying stock in Skillz Inc, ZK International, Idera Pharmaceuticals, Upstart Holdings, or Plug Power?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SKLZ, ZKIN, IDRA, UPST, and PLUG.

UPST : 323.51 (+0.85%)
IDRA : 1.0500 (+2.94%)
PLUG : 26.92 (+3.22%)
ZKIN : 3.09 (+3.69%)
SKLZ : 11.24 (+6.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Idera Pharmaceuticals, Inc. is a drug discovery and development company that is developing drug candidates to treat cancer and infectious, respiratory, and autoimmune diseases, and for use in combination with therapeutic and prophylactic vaccines. Idera's proprietary drug candidates are designed to modulate...

See More

Key Turning Points

3rd Resistance Point 1.1035
2nd Resistance Point 1.0768
1st Resistance Point 1.0634
Last Price 1.0500
1st Support Level 1.0233
2nd Support Level 0.9966
3rd Support Level 0.9832

See More

52-Week High 6.1400
Fibonacci 61.8% 4.1654
Fibonacci 50% 3.5555
Fibonacci 38.2% 2.9456
Last Price 1.0500
52-Week Low 0.9710

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar